Are you Dr. Palumbo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Infectious Disease Dartmouthhitchcock Med CTR
Lebanon, NH 03756Phone+1 603-650-8840Fax+1 603-650-6199
Summary
- Dr. Paul Palumbo, MD is a pediatric infectious disease specialist in Lebanon, New Hampshire. He is currently licensed to practice medicine in New Hampshire, Maine, and New Jersey. He is affiliated with Dartmouth-Hitchcock Medical Center and is a Professor at Geisel School of Medicine.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1980 - 1982
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Pediatrics, 1979 - 1980
- Virginia Commonwealth University Health SystemResidency, Pediatrics, 1977 - 1979
- University of Vermont College of MedicineClass of 1977
Certifications & Licensure
- NH State Medical License 2007 - 2025
- ME State Medical License 2020 - 2021
- NJ State Medical License 1988 - 2007
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses
- Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV Start of enrollment: 2005 Dec 01
Publications & Presentations
PubMed
- 2 citationsHIV in Neonates and Infants.Andres Camacho-Gonzalez, Paul Palumbo
Clinics in Perinatology. 2021-06-01 - 26 citationsAfrican Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus.Michael J. Boivin, Miriam Chernoff, Lee Fairlie, Barbara Laughton, Bonnie Zimmer
Clinical Infectious Diseases. 2020-10-23 - 30 citationsLong-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.Rolando M. Viani, Theodore Ruel, Carmelita Alvero, Terry Fenton, Edward P. Acosta
Journal of the Pediatric Infectious Diseases Society. 2020-04-30
Press Mentions
- Dartmouth-Hitchcock Roundtable Addresses Parent Concerns over Vaccinations for KidsJune 8th, 2021
Grant Support
- New Jersey Pediatric AIDS Clinical Trials ConsortiumNational Institute Of Allergy And Infectious Diseases2002–2005
- New Jersey Pediatric AIDS ConsortiumNational Institute Of Allergy And Infectious Diseases1999–2001
- Viral &Immune Elements In Early Pediatric HIV InfectionNational Institute Of Allergy And Infectious Diseases1995–1999